ctrl K

AI Score

Unlock

Revelation Biosciences In... (REVB)

AI Score

Unlock

3.51

-0.03 (-0.85%)

At close: Feb 28, 2025, 3:59 PM

3.33

-5.14%

After-hours: Feb 28, 2025, 04:59 PM EST

Revelation Biosciences Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Cash & Equivalents	11.99M	5.25M	1.27M	4.49M	n/a
Short-Term Investments	n/a	n/a	n/a	525.29K	n/a
Long-Term Investments	n/a	n/a	n/a	73.51M	n/a
Other Long-Term Assets	n/a	n/a	0.00	n/a	22.67K
Receivables	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	155.82K	160.3K	637.34K	128K	n/a
Total Current Assets	12.15M	5.41M	1.91M	4.62M	n/a
Property-Plant & Equipment	65.08K	90.13K	130.14K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	65.08K	90.13K	130.14K	73.51M	22.67K
Total Assets	12.21M	5.5M	2.04M	4.62M	22.67K
Account Payables	1.36M	554.21K	596.26K	865.9K	n/a
Deferred Revenue	n/a	2.91M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	16.75K	n/a	n/a
Other Current Liabilities	4.2M	3.9M	1.53M	342.88K	26.31K
Total Current Liabilities	5.56M	4.45M	2.14M	1.21M	26.31K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	554.21K	2.91M	2.91M	n/a
Total Liabilities	5.56M	4.45M	2.14M	1.21M	26.31K
Total Debt	n/a	n/a	16.75K	n/a	n/a
Common Stock	265.00	683.00	2.31K	2.29K	n/a
Retained Earnings	-25.47M	-25.35M	-14.52M	-2.53M	-3.64K
Comprehensive Income	-0.00	n/a	-0.00	n/a	n/a
Shareholders Equity	6.65M	1.05M	-99.47K	3.41M	-3.64K
Total Investments	n/a	n/a	n/a	525.29K	n/a